Bergeron R M, Desai K, Serron S C, Cawley G F, Eyer C S, Backes W L
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, New Orleans, Louisiana 70112, USA.
Toxicol Appl Pharmacol. 1999 May 15;157(1):1-8. doi: 10.1006/taap.1999.8656.
Treatment of rats with ethylbenzene (EB) modulates the hepatic expression of many P450s, with those induced after a single intraperitoneal hydrocarbon injection differing from those induced after more prolonged (3 day) administration. The goals of the current studies are (1) to characterize the induction response after prolonged hydrocarbon exposure, (2) to explain why the elevation of these P450s is attenuated after continued treatment, and (3) to determine how P450 2B protein remains elevated without an elevation of P450 2B1/2 RNA. P450 2C11 protein was decreased after a single EB injection and remained depressed throughout the treatment period. P450 2C11 RNA was only decreased with prolonged, but not acute treatment. P450 2E1 was induced after a single EB injection; however, the initial induction was attenuated with more prolonged treatment. P450 2B1 and P450 2B2 RNAs exhibited a similar response, being elevated after acute administration, but returned to control levels with prolonged EB administration. Interestingly, P450 2B protein levels remained elevated despite the decrease in P450 2B1 and P450 2B2 RNA to control levels. We then tested the possibility that the multiphasic induction pattern of P450 2E1 and P450 2B1/2 RNA was due to differences in the pharmacokinetics of EB. The disappearance of EB with time was measured in rats that were either (1) untreated, (2) pretreated with EB for 1 day, or (3) pretreated with EB for 3 days. These results demonstrated that prior hydrocarbon exposure caused an increase in EB clearance, which decreased the overall levels of EB in the body. Consequently, EB levels were sufficiently diminished to decrease EB's effectiveness as an inducer leading to the decrease in P450 2E1 protein and P450 2B1 and P450 2B2 RNA after continued EB administration. A further consequence of the decreased overall EB concentration is that the hydrocarbon was capable of producing only a transient elevation of P450 2B1 RNA levels. This transient elevation appears to be sufficient to maintain elevated P450 2B protein.
用乙苯(EB)处理大鼠可调节多种细胞色素P450的肝脏表达,单次腹腔注射碳氢化合物后诱导的细胞色素P450与更长时间(3天)给药后诱导的不同。当前研究的目的是:(1)描述长时间碳氢化合物暴露后的诱导反应;(2)解释持续治疗后这些细胞色素P450的升高为何减弱;(3)确定细胞色素P450 2B蛋白在细胞色素P450 2B1/2 RNA未升高的情况下如何保持升高。单次注射EB后,细胞色素P450 2C11蛋白减少,并在整个治疗期间持续降低。细胞色素P450 2C11 RNA仅在长时间而非急性治疗后降低。单次注射EB后可诱导细胞色素P450 2E1;然而,随着治疗时间延长,最初的诱导作用减弱。细胞色素P450 2B1和细胞色素P450 2B2 RNA表现出类似的反应,急性给药后升高,但随着EB长时间给药又恢复到对照水平。有趣的是,尽管细胞色素P450 2B1和细胞色素P450 2B2 RNA降至对照水平,但细胞色素P450 2B蛋白水平仍保持升高。然后,我们测试了细胞色素P450 2E1和细胞色素P450 2B1/2 RNA多相诱导模式是否因EB药代动力学差异所致的可能性。在以下大鼠中测量了EB随时间的消失情况:(1)未处理的;(2)用EB预处理1天的;或(3)用EB预处理3天的。这些结果表明,先前的碳氢化合物暴露导致EB清除率增加,从而降低了体内EB的总体水平。因此,EB水平充分降低,降低了EB作为诱导剂的效力,导致持续给予EB后细胞色素P450 2E1蛋白以及细胞色素P450 2B1和细胞色素P450 2B2 RNA减少。总体EB浓度降低的另一个后果是,该碳氢化合物仅能使细胞色素P450 2B1 RNA水平产生短暂升高。这种短暂升高似乎足以维持细胞色素P450 2B蛋白的升高。